Prostate cancer decisions — 2023

The Veteran's prostate cancer residuals are being remanded for further evaluation to determine the approximate date of remission.

The Veteran's claims for service connection for colon cancer (originally claimed as prostate cancer) and a throat condition have been denied. The Board found that there is no direct evidence linking the conditions to his military service or any presumptive exposure, and the medical opinions provided did not support a nexus between the conditions and herbicide exposure.

The Board denied the Veteran's request for an earlier effective date for service connection of prostate cancer, as the claim was granted under the PACT Act and the earliest effective date is August 10, 2022.

The Veteran's prostate cancer, post-radical prostatectomy, was granted a 60% disability rating effective November 5, 2015. The issue of an increased rating for adjustment disorder with depressed mood is remanded.

The Board has determined that the reduction in evaluation of prostate cancer from 100 percent to 20 percent effective July 1, 2020 was proper and restored a 100 percent rating is not warranted.

The Board has determined that the discontinuance of the 100 percent disability rating for prostate cancer was proper, and has assigned a 20 percent rating for residuals of prostate cancer based on voiding dysfunction.

The Veteran's prostate cancer is being remanded for further development to confirm his exposure to herbicide agents during service in Panama.

Your appeals for service connection for prostate cancer and coronary artery disease have been dismissed as the Veteran withdrew his appeal.

The Board has remanded the case due to insufficient evidence to decide the claim, including lack of evidence supporting service in Vietnam and no facts to fully support theories of service connection. The Veteran's exposure to contaminated water at Camp Lejeune is not associated with prostate cancer.

The Veteran's claim for service connection for prostate cancer is remanded due to insufficient verification of herbicide agent exposure. The Board found the response from MRCC inadequate and requires further investigation.

The Board has remanded the claims for entitlement to service connection for prostate cancer and paroxysmal atrial fibrillation due to a failure to provide notice of the right to a pre-decisional hearing.

The Board has remanded the claims for prostate cancer and its secondary disabilities due to pre-decisional duty to assist errors, including failure to obtain private medical records and an inadequate VA opinion. The appellant is seeking compensation under 38 U.S.C. § 1151 for prostate cancer and service connection for various disabilities as secondary to his prostate cancer.

The Veteran's claim for a higher rating for prostate cancer residuals is being remanded due to the failure of the Veteran to report for a scheduled VA examination. The case will be reconsidered with a new examination.

The Board has determined that new and relevant evidence has been submitted to support the claims of service connection for CAD, high blood pressure, DM, prostate cancer, erectile dysfunction, incontinence, and scars. The claims are being remanded due to concerns about herbicide exposure near the Korean DMZ.

The Veteran's appeal for a higher rating for prostate cancer and for an increased rating for erectile dysfunction (ED) is remanded due to the need for additional development of his medical records.,Specifically, the Board requests that the Veteran provide authorization for VA to obtain private treatment records from Baptist East in Memphis related to his prostate cancer.

The Veteran's service-connected disabilities, including prostate cancer and PTSD, do not render him unemployable due to their combined effect on his ability to secure or follow substantially gainful employment.

The Board has remanded the Veteran's claims for service connection due to his death during the appeal process. The case is now being reviewed with consideration of the appellant's eligibility for accrued benefits.

The Board has remanded the Veteran's claim for a compensable disability rating prior to April 12, 2010, and for a disability rating in excess of 40 percent since that date due to inconsistencies in the evidence regarding his urinary dysfunction.

The Veteran withdrew his appeals regarding the claims for prostate cancer, hearing loss, and left wrist fracture before a decision was made.

The Board has granted an earlier effective date of June 26, 2015 for the award of service connection for residuals of prostate cancer and special monthly compensation (SMC) under the provisions of 38 U.S.C. § 1114(k). This was due to a finding of clear and unmistakable error in the April 2020 rating decision.